Entering text into the input field will update the search result below

MannKind Corporation (MNKD) CEO Mike Castagna Presents at Lytham Partners Fall Conference (Transcript)

Oct. 05, 2021 2:55 PM ETMannKind Corporation (MNKD)
SA Transcripts profile picture
SA Transcripts

MannKind Corporation (NASDAQ:MNKD) Lytham Partners Fall Conference Call October 5, 2021 11:45 AM ET

Company Participants

Mike Castagna - Chief Executive Officer

Conference Call Participants

Robert Blum - Lytham Partners

Robert Blum

Alright. Hello, everyone. Good morning and thank you all for joining us during the Lytham Partners Fall 2021 Investor Conference. My name is Robert Blum, Managing Partner of Lytham Partners. Our next presentation comes from MannKind, ticker symbol MNKD on the NASDAQ and presenting from the company is its Chief Executive Officer, Mike Castagna. A copy of the slide presentation is available on your screen and today, I have asked Mike to run through the slide presentation. And if there are any questions that pop up afterwards, please feel free to reach out to me or the company and we will look to coordinate getting those taken care of for you. Also, if there are additional one-on-one meeting requests out there, please reach out to me. Again, my e-mail is blum@lythampartners.com. And I will look to help coordinate that for you.

With that said, let me turn the presentation over to Mike Castagna, Chief Executive Officer of MannKind. Mike, please proceed.

Mike Castagna

Hi, thank you for having me this morning. I appreciate it. Hope everyone is having a great Tuesday. I want to give everyone a quick update on MannKind. Our first slide here is our corporate forward-looking statement. Anything can change from here on out. I want to remind people for those who don’t know MannKind, little bit of background on the company and our mission and strategy. Our mission is to give people control of their health and the freedom to live life. We call that life more human. When you think about our technology and what we do is really alleviate symptoms that happen to patients such as pulmonary hypertension or high sugars in the

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About MNKD

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on MNKD

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.